Literature DB >> 28684998

Bioactive M(II) complexes of amino acid-based N3O donor mixed ligand: in vitro and in silico DNA binding studies.

T Daniel Prakash1, V Violet Dhayabaran1.   

Abstract

Three novel mixed ligand M(II) complexes, namely [CoL1L2Cl2] (1), [CuL1L2Cl2] (2), and [ZnL1L2Cl2] (3), were synthesized using 1,4-naphthoquinone, L-histidine, and 1,10-phenanthroline as ligands. The ligand framework and the corresponding structural changes on complexation were ascertained based on the results of elemental analysis, conductivity measurements, magnetic behavior, FT-IR, UV-visible, 1H NMR, 13C NMR, ESR spectral studies, and ESI mass spectrometry. The biological action of the ligand (L) and complexes 1-3 such as DNA binding and cleaving ability were studied. Results suggest that the ligand and the complexes could interact with calf thymus-DNA (CT-DNA) via intercalation mode. Additionally, complex 2 displayed potential antioxidant activity in in vitro studies. Docking simulation was performed to position the ligand and the complexes into the active site of BDNA (IBNA) to determine the probable binding mode.

Entities:  

Keywords:  Antioxidant activity; DNA binding; DNA cleavage; Mixed ligand complexes; Molecular docking

Year:  2017        PMID: 28684998      PMCID: PMC5480264          DOI: 10.1007/s12154-017-0170-3

Source DB:  PubMed          Journal:  J Chem Biol        ISSN: 1864-6158


  18 in total

Review 1.  Circular dichroism and the interactions of water soluble porphyrins with DNA.

Authors:  Robert F Pasternack
Journal:  Chirality       Date:  2003-05-05       Impact factor: 2.437

2.  Cu(II)-dipeptide complexes of 2-(4'-thiazolyl)benzimidazole: synthesis, DNA oxidative damage, antioxidant and in vitro antitumor activity.

Authors:  Xia-Bing Fu; Jia-Jia Zhang; Dan-Dan Liu; Qian Gan; Hong-Wei Gao; Zong-Wan Mao; Xue-Yi Le
Journal:  J Inorg Biochem       Date:  2014-12-10       Impact factor: 4.155

Review 3.  Metal complexes with aromatic N-containing ligands as potential agents in cancer treatment.

Authors:  Guanghua Zhao; Huakuan Lin
Journal:  Curr Med Chem Anticancer Agents       Date:  2005-03

4.  Bio-relevant complexes of novel N2O2 type heterocyclic ligand: Synthesis, structural elucidation, biological evaluation and docking studies.

Authors:  T Arun; S Packianathan; M Malarvizhi; R Antony; N Raman
Journal:  J Photochem Photobiol B       Date:  2015-05-29       Impact factor: 6.252

5.  EPR, IR and electronic spectral studies on Mn(II), Co(II), Ni(II) and Cu(II) complexes with a new 22-membered azamacrocyclic [N4] ligand.

Authors:  Sulekh Chandra; Lokesh Kumar Gupta
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2004-07       Impact factor: 4.098

6.  Influence of aglycone modifications on the binding of anthracycline drugs to DNA: the molecular structure of idarubicin and 4-O-demethyl-11-deoxydoxorubicin complexed to d(CGATCG).

Authors:  Y G Gao; A H Wang
Journal:  Anticancer Drug Des       Date:  1991-07

7.  Influence of Amino Acid-Nucleobase Hybrid Ligand in Binding and Biological Activity of Co(II) and Zn(II) Complexes.

Authors:  V Violet Dhayabaran; T Daniel Prakash
Journal:  J Fluoresc       Date:  2016-07-15       Impact factor: 2.217

8.  Metal based pharmacologically active complexes of Cu(II), Ni(II) and Zn(II): synthesis, spectral, XRD, antimicrobial screening, DNA interaction and cleavage investigation.

Authors:  Natarajan Raman; Rajkumar Mahalakshmi; T Arun; S Packianathan; R Rajkumar
Journal:  J Photochem Photobiol B       Date:  2014-06-12       Impact factor: 6.252

9.  Synthesis, characterization and in vitro DNA binding and cleavage studies of Cu(II)/Zn(II) dipeptide complexes.

Authors:  Farukh Arjmand; A Jamsheera; D K Mohapatra
Journal:  J Photochem Photobiol B       Date:  2013-02-26       Impact factor: 6.252

10.  A novel cytotoxic ternary copper(II) complex of 1,10-phenanthroline and L-threonine with DNA nuclease activity.

Authors:  Shouchun Zhang; Yangguang Zhu; Chao Tu; Haiying Wei; Zhen Yang; Liping Lin; Jian Ding; Junfeng Zhang; Zijian Guo
Journal:  J Inorg Biochem       Date:  2004-12       Impact factor: 4.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.